Paywalled, but not a huge surprise really. Sounds like part of the problem was the internal pharma team not having a plan for what to use CoPilot for and going for the "it's AI!" theme from Microsoft.<p>I am seeing great value in AI-based solutions related to knowledge assistants and for automation N(A). Neither of these seem like strong suites for CoPilot, but it's very early days.<p>That we're seeing much better results using self-hosted open source models (Llama 3.1, etc.) should be concerning for Microsoft as well.